BioGend Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 610,775 | 0.492% |
| Institutions | 3,184,000 | 2.56% |
| Private Companies | 3,278,000 | 2.64% |
| Public Companies | 41,197,008 | 33.2% |
| General Public | 75,986,243 | 61.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 37,580,008 | NT$1.5b | 0% | no data | |||
| 3,617,000 | NT$139.8m | 0% | no data | |||
| 2,158,000 | NT$83.4m | 0% | no data | |||
| 2,000,000 | NT$77.3m | 0% | 2.69% | |||
| 1,120,000 | NT$43.3m | 0% | no data | |||
| 1,083,000 | NT$41.9m | 0% | 8.92% | |||
| 610,775 | NT$23.6m | 0% | no data | |||
| 101,000 | NT$3.9m | 0% | no data |